LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MDA-MB-231 Fedratinib
0.37
uM
LJP5
 1
L04
 72
hr
 1311 4964 5128 0.9680 0.9672
MDA-MB-231 Fedratinib
0.37
uM
LJP5
 2
L04
 72
hr
 1311 4798 5100 0.9408 0.9386
MDA-MB-231 Fedratinib
0.37
uM
LJP5
 3
L04
 72
hr
 1311 4896 5010 0.9771 0.9762
MDA-MB-231 Fedratinib
1.11
uM
LJP5
 1
L03
 72
hr
 1311 4390 5128 0.8560 0.8480
MDA-MB-231 Fedratinib
1.11
uM
LJP5
 2
L03
 72
hr
 1311 4446 5100 0.8718 0.8647
MDA-MB-231 Fedratinib
1.11
uM
LJP5
 3
L03
 72
hr
 1311 4147 5010 0.8276 0.8136
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 1
L02
 72
hr
 1311 2156 5128 0.4204 0.2874
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 2
L02
 72
hr
 1311 2224 5100 0.4361 0.3093
MDA-MB-231 Fedratinib
3.33
uM
LJP5
 3
L02
 72
hr
 1311 2289 5010 0.4568 0.3337
MDA-MB-231 Fedratinib
10
uM
LJP5
 1
L01
 72
hr
 1311 583 5128 0.1137 -0.3378
MDA-MB-231 Fedratinib
10
uM
LJP5
 2
L01
 72
hr
 1311 766 5100 0.1502 -0.2401
MDA-MB-231 Fedratinib
10
uM
LJP5
 3
L01
 72
hr
 1311 577 5010 0.1152 -0.3461
MDA-MB-231 Trametinib
0.04
uM
LJP5
 1
P24
 72
hr
 1311 1530 5128 0.2983 0.0814
MDA-MB-231 Trametinib
0.04
uM
LJP5
 2
P24
 72
hr
 1311 1592 5100 0.3122 0.1039
MDA-MB-231 Trametinib
0.04
uM
LJP5
 3
P24
 72
hr
 1311 1672 5010 0.3337 0.1337
MDA-MB-231 Trametinib
0.12
uM
LJP5
 1
P23
 72
hr
 1311 1708 5128 0.3331 0.1436
MDA-MB-231 Trametinib
0.12
uM
LJP5
 2
P23
 72
hr
 1311 1792 5100 0.3514 0.1726
MDA-MB-231 Trametinib
0.12
uM
LJP5
 3
P23
 72
hr
 1311 1719 5010 0.3431 0.1501
MDA-MB-231 Trametinib
0.37
uM
LJP5
 1
P22
 72
hr
 1311 1647 5128 0.3212 0.1227
MDA-MB-231 Trametinib
0.37
uM
LJP5
 2
P22
 72
hr
 1311 1780 5100 0.3490 0.1686
MDA-MB-231 Trametinib
0.37
uM
LJP5
 3
P22
 72
hr
 1311 1621 5010 0.3235 0.1157
MDA-MB-231 Trametinib
1.11
uM
LJP5
 1
P21
 72
hr
 1311 1636 5128 0.3190 0.1189
MDA-MB-231 Trametinib
1.11
uM
LJP5
 2
P21
 72
hr
 1311 1797 5100 0.3524 0.1743
MDA-MB-231 Trametinib
1.11
uM
LJP5
 3
P21
 72
hr
 1311 1760 5010 0.3512 0.1642
MDA-MB-231 Trametinib
3.33
uM
LJP5
 1
P20
 72
hr
 1311 1702 5128 0.3319 0.1416